KPP Advisory Services LLC Grows Stock Position in CVS Health Co. (NYSE:CVS)

KPP Advisory Services LLC grew its position in shares of CVS Health Co. (NYSE:CVS) by 3.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,562 shares of the pharmacy operator’s stock after buying an additional 322 shares during the period. KPP Advisory Services LLC’s holdings in CVS Health were worth $565,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health during the 4th quarter valued at $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health during the fourth quarter valued at about $34,000. Steph & Co. lifted its holdings in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares in the last quarter. Kapitalo Investimentos Ltda bought a new position in shares of CVS Health in the fourth quarter valued at approximately $36,000. Finally, Scarborough Advisors LLC bought a new stake in CVS Health during the 4th quarter worth approximately $37,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the stock. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Monday, September 16th. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Wells Fargo & Company lifted their price target on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Barclays dropped their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research report on Thursday, August 8th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Eleven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $72.10.

CVS Health Stock Performance

NYSE:CVS opened at $62.84 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The business has a 50 day moving average price of $58.29 and a 200-day moving average price of $61.77. The firm has a market cap of $78.89 billion, a PE ratio of 11.04, a price-to-earnings-growth ratio of 0.81 and a beta of 0.53.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The firm had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.21 earnings per share. Equities research analysts predict that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a $0.665 dividend. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.23%. CVS Health’s dividend payout ratio is currently 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.